Skip to content

Use of Misoprostol for Intrauterine Device (IUD) Insertion in Nulliparous Women

A Randomized Control Trial of Misoprostol vs. Placebo for Cervical Preparation in IUD Insertion for Nulliparous Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01001897
Enrollment
61
Registered
2009-10-27
Start date
2009-10-31
Completion date
2011-04-30
Last updated
2012-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

IUD insertion, nulliparous women, contraception

Brief summary

The purpose of this study is to evaluate if the use of misoprostol can make it easier for a provider, and less painful for a woman, to place an IUD if she has never had a child before.

Detailed description

IUD's are a tremendously effective long acting, reversible method of contraception, and they require little participation from the woman after insertion. Despite these benefits, few women in the US use an IUD. Education is important so that both providers and women understand that IUD's are safe and effective in women even if they have never had a child. Insertion of an IUD in nulliparous patients can be more difficult and uncomfortable. The purpose of this study is to see if use of misoprostol prior to IUD placement in nulliparous women can make it easier and less painful. The goal is that more information on the feasibility and ease of IUD insertion will make it more accessible to more women. The findings from this trial will be used in a prospective meta analysis on this topic.

Interventions

DRUGMisoprostol

400 micrograms of misoprostol or placebo inserted buccally or vaginally prior to IUD insertion

DRUGPlacebo

400 micrograms of misoprostol or placebo inserted buccally or vaginally prior to IUD insertion

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Nulliparous, no prior pregnancy beyond 14 week * Over 18 years of age * Negative pregnancy test

Exclusion criteria

* current pregnancy or pregnancy within 6 weeks * current cervicitis or PID (active or within 3 months) * undiagnosed abnormal uterine bleeding * allergy to copper/ Wilson's disease (for Paragard) * cervical or uterine cancer * uterine anomaly altering uterine cavity

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is worst perceived pain during the IUD insertion procedure, on a 100 mm visual analogue scaleafter IUD insertion

Secondary

MeasureTime frame
Side effects of medicationsprior to IUD insertion
Provider perceived ease of insertion on a 100 mm visual analogue scaleafter IUD insertion
Need to use adjuvant measures for IUD placement, such as dilation, ultrasound guidance, anesthesiaduring IUD insertion
Procedure complicationsUp to 1 month after IUD placement
Acceptability of total IUD placement process, would you recommend this to a friend?1 week and 1 month after IUD insertion
Acceptability of wait time prior to IUD placement1 week after IUD insertion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026